HARROW, INC. (HROW) Form 10-Q Quarterly Reports
HARROW, INC. (HROW) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HROW
CIK: 1360214
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerBrian Whisnant
Audit LocationNashville, Tennessee, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-05 | 2026-10-01 | 8-K | 0001628280-26-064749 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-09-04 | 8-K | 0001493152-26-041569 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001493152-26-039748 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | 4 | 0001493152-26-038807 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001628280-26-055271 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001493152-26-036865 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-03 | 8-K | 0001493152-26-036256 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0001493152-26-035624 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001493152-26-029659 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001493152-26-029658 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001493152-26-029657 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | 8-K | 0001493152-26-029486 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | 8-K | 0001493152-26-026983 | View SEC Doc Filr Page |
| 4 | 2026-05-19 | 2026-05-18 | 4 | 0001493152-26-024342 | View SEC Doc Filr Page |
| 4 | 2026-05-19 | 2026-05-18 | 4 | 0001493152-26-024341 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-15 | 4 | 0001493152-26-024208 | View SEC Doc Filr Page |
| 4 | 2026-05-15 | 2026-05-14 | 4 | 0001493152-26-023321 | View SEC Doc Filr Page |
| 4 | 2026-05-15 | 2026-05-14 | 4 | 0001493152-26-023319 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001493152-26-022254 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-11 | — | SCHEDULE 13G/A Filing | 0001493152-26-022235 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001493152-26-022227 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-24 | — | DEFA14A | 0001493152-26-018914 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2025-12-31 | DEF 14A | 0001493152-26-018912 | View SEC Doc Filr Page |
| 8-K | 2026-03-27 | 2026-03-24 | 8-K | 0001493152-26-013199 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-27 | — | SCHEDULE 13G/A Filing | 0000102909-26-001499 | View SEC Doc Filr Page |